Cognitive-Behavioural Therapy for Inflammatory Bowel Disease: 24-Month Data from a Randomised Controlled Trial

Antonina Mikocka-Walus, Peter Bampton, David Hetzel, Patrick Hughes, Adrian Esterman, Jane M. Andrews

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Purpose: There is ongoing controversy on the effectiveness of psychotherapy in inflammatory bowel disease (IBD). In the few small studies, cognitive-behavioural therapy (CBT) has been shown to alleviate symptoms of anxiety or depression. However, there is little research on the impact of CBT on physical outcomes in IBD and no studies on long-term effectiveness of CBT. Methods: The present two-arm pragmatic randomised controlled trial aimed to establish the impact of CBT on disease course after 24 months of observation. The study compared standard care plus CBT (+CBT) with standard care alone (SC). CBT was delivered over 10 weeks, face-to-face (F2F) or online (cCBT). The data were analysed using linear mixed-effects models. Results: CBT did not significantly influence disease activity as measured by disease activity indices at 24 months (Crohn’s Disease Activity Index (CDAI), p = 0.92; Simple Clinical Colitis Activity Index (SCCAI), p = 0.88) or blood parameters (C-reactive protein (CRP), p < 0.62; haemoglobin (Hb), p = 0.77; platelet, p = 0.64; white cell count (WCC), p = 0.59) nor did CBT significantly affect mental health, coping or quality of life (all p > 0.05). Conclusions: Therefore, we conclude that CBT does not influence the course of IBD over 24 months. Given the high rate of attrition, particularly in the CBT group, future trials should consider a personalised approach to psychotherapy, perhaps combining online and one-to-one therapist time.

LanguageEnglish
Pages127-135
Number of pages9
JournalInternational Journal of Behavioral Medicine
Volume24
Issue number1
DOIs
Publication statusPublished - 1 Feb 2017

Keywords

  • Cognitive-behavioural therapy
  • Disease course
  • Inflammatory bowel disease

ASJC Scopus subject areas

  • Applied Psychology

Cite this

Mikocka-Walus, Antonina ; Bampton, Peter ; Hetzel, David ; Hughes, Patrick ; Esterman, Adrian ; Andrews, Jane M. / Cognitive-Behavioural Therapy for Inflammatory Bowel Disease : 24-Month Data from a Randomised Controlled Trial. In: International Journal of Behavioral Medicine. 2017 ; Vol. 24, No. 1. pp. 127-135.
@article{d3e064c8016e43058b8bfc62b7cb2f24,
title = "Cognitive-Behavioural Therapy for Inflammatory Bowel Disease: 24-Month Data from a Randomised Controlled Trial",
abstract = "Purpose: There is ongoing controversy on the effectiveness of psychotherapy in inflammatory bowel disease (IBD). In the few small studies, cognitive-behavioural therapy (CBT) has been shown to alleviate symptoms of anxiety or depression. However, there is little research on the impact of CBT on physical outcomes in IBD and no studies on long-term effectiveness of CBT. Methods: The present two-arm pragmatic randomised controlled trial aimed to establish the impact of CBT on disease course after 24 months of observation. The study compared standard care plus CBT (+CBT) with standard care alone (SC). CBT was delivered over 10 weeks, face-to-face (F2F) or online (cCBT). The data were analysed using linear mixed-effects models. Results: CBT did not significantly influence disease activity as measured by disease activity indices at 24 months (Crohn’s Disease Activity Index (CDAI), p = 0.92; Simple Clinical Colitis Activity Index (SCCAI), p = 0.88) or blood parameters (C-reactive protein (CRP), p < 0.62; haemoglobin (Hb), p = 0.77; platelet, p = 0.64; white cell count (WCC), p = 0.59) nor did CBT significantly affect mental health, coping or quality of life (all p > 0.05). Conclusions: Therefore, we conclude that CBT does not influence the course of IBD over 24 months. Given the high rate of attrition, particularly in the CBT group, future trials should consider a personalised approach to psychotherapy, perhaps combining online and one-to-one therapist time.",
keywords = "Cognitive-behavioural therapy, Disease course, Inflammatory bowel disease",
author = "Antonina Mikocka-Walus and Peter Bampton and David Hetzel and Patrick Hughes and Adrian Esterman and Andrews, {Jane M.}",
year = "2017",
month = "2",
day = "1",
doi = "10.1007/s12529-016-9580-9",
language = "English",
volume = "24",
pages = "127--135",
journal = "International Journal of Behavioral Medicine",
issn = "1070-5503",
publisher = "Routledge",
number = "1",

}

Cognitive-Behavioural Therapy for Inflammatory Bowel Disease : 24-Month Data from a Randomised Controlled Trial. / Mikocka-Walus, Antonina; Bampton, Peter; Hetzel, David; Hughes, Patrick; Esterman, Adrian; Andrews, Jane M.

In: International Journal of Behavioral Medicine, Vol. 24, No. 1, 01.02.2017, p. 127-135.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cognitive-Behavioural Therapy for Inflammatory Bowel Disease

T2 - International Journal of Behavioral Medicine

AU - Mikocka-Walus, Antonina

AU - Bampton, Peter

AU - Hetzel, David

AU - Hughes, Patrick

AU - Esterman, Adrian

AU - Andrews, Jane M.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Purpose: There is ongoing controversy on the effectiveness of psychotherapy in inflammatory bowel disease (IBD). In the few small studies, cognitive-behavioural therapy (CBT) has been shown to alleviate symptoms of anxiety or depression. However, there is little research on the impact of CBT on physical outcomes in IBD and no studies on long-term effectiveness of CBT. Methods: The present two-arm pragmatic randomised controlled trial aimed to establish the impact of CBT on disease course after 24 months of observation. The study compared standard care plus CBT (+CBT) with standard care alone (SC). CBT was delivered over 10 weeks, face-to-face (F2F) or online (cCBT). The data were analysed using linear mixed-effects models. Results: CBT did not significantly influence disease activity as measured by disease activity indices at 24 months (Crohn’s Disease Activity Index (CDAI), p = 0.92; Simple Clinical Colitis Activity Index (SCCAI), p = 0.88) or blood parameters (C-reactive protein (CRP), p < 0.62; haemoglobin (Hb), p = 0.77; platelet, p = 0.64; white cell count (WCC), p = 0.59) nor did CBT significantly affect mental health, coping or quality of life (all p > 0.05). Conclusions: Therefore, we conclude that CBT does not influence the course of IBD over 24 months. Given the high rate of attrition, particularly in the CBT group, future trials should consider a personalised approach to psychotherapy, perhaps combining online and one-to-one therapist time.

AB - Purpose: There is ongoing controversy on the effectiveness of psychotherapy in inflammatory bowel disease (IBD). In the few small studies, cognitive-behavioural therapy (CBT) has been shown to alleviate symptoms of anxiety or depression. However, there is little research on the impact of CBT on physical outcomes in IBD and no studies on long-term effectiveness of CBT. Methods: The present two-arm pragmatic randomised controlled trial aimed to establish the impact of CBT on disease course after 24 months of observation. The study compared standard care plus CBT (+CBT) with standard care alone (SC). CBT was delivered over 10 weeks, face-to-face (F2F) or online (cCBT). The data were analysed using linear mixed-effects models. Results: CBT did not significantly influence disease activity as measured by disease activity indices at 24 months (Crohn’s Disease Activity Index (CDAI), p = 0.92; Simple Clinical Colitis Activity Index (SCCAI), p = 0.88) or blood parameters (C-reactive protein (CRP), p < 0.62; haemoglobin (Hb), p = 0.77; platelet, p = 0.64; white cell count (WCC), p = 0.59) nor did CBT significantly affect mental health, coping or quality of life (all p > 0.05). Conclusions: Therefore, we conclude that CBT does not influence the course of IBD over 24 months. Given the high rate of attrition, particularly in the CBT group, future trials should consider a personalised approach to psychotherapy, perhaps combining online and one-to-one therapist time.

KW - Cognitive-behavioural therapy

KW - Disease course

KW - Inflammatory bowel disease

UR - http://www.scopus.com/inward/record.url?scp=84978646039&partnerID=8YFLogxK

U2 - 10.1007/s12529-016-9580-9

DO - 10.1007/s12529-016-9580-9

M3 - Article

VL - 24

SP - 127

EP - 135

JO - International Journal of Behavioral Medicine

JF - International Journal of Behavioral Medicine

SN - 1070-5503

IS - 1

ER -